{'Year': '2015'}
Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy.
To determine the frequency of pharmacogenomic variants and concurrent medications that may alter the efficacy and tolerability of acetylcholinesterase inhibitors (AChEIs).